Dr Michael Huang

NHMRC Peter Doherty Research Fellow
School of Medical Sciences
Department of Pathology

Telephone 90363035

Map

Selected grants

2018

  • Bridging Support Fellowship- Huang; Huang M; DVC Research/Bridging Support Fellowship.
  • Intercepting the Hormone Hepcidin to Treat the Anaemia of Chronic Disease; Huang M; Rebecca L Cooper Medical Research Foundation/Research Grant.

2017

  • Commercial Translation of Innovative Null Hepcidin Analogs that Prevent the Anaemia of Chronic Disease; Richardson D, Meyer-Carrive I, Huang M; National Foundation for Medical Research and Innovation (NFMRI)/Social Investment Portfolio 2.
  • Hormone Transport by Alpha-2-Macroglobulin: Novel Roles in Regulating Hormone Activity; Richardson D, Subramaniam N, Trinder D, Huang M, Clark R, Ganz T; National Health and Medical Research Council (NHMRC)/Project Grants.

2016

  • Targeting Mitochondrial Homeostasis in the Pathogenesis of Friedreich's Ataxia; Huang M, Richardson D; Muscular Dystrophy Association (USA)/Research Support.

2014

  • Dissecting the Pathogenesis of the Severe Neurodegenerative Disease, Friedreichs Ataxia: Development of Novel Therapeutics; Huang M; National Health and Medical Research Council (NHMRC)/Early Career Fellowships.
  • CLARIOstar Multifunctional Microplate Reader for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Huang M, Scolyer R, Fraser S, Sahni S, Speranza T, Owens T, Barrs V, Ju Y, Kovacevic Z, Lu Z, Camp A, Slobedman B, Morris B, Oliver B, Dos Remedios C, Kalinowski D, Fu D, Lai D, Lovicu F, Allbutt H, Triccas J, Burgess J, Kril J, Dixon K, Rendina L, Byrne M, King N, Groundwater P, Williamson P, Ho P, Dong Q, Bao B, Assinder S, McLennan S, Richardson D, Ammit A, Sharland A, Hardikar A, Hong A, Hambly B, Lee C, Murphy C, Goldsbury C, Johnstone D, Lane D, Hibbs D, Joshua D, Huq F, Halliday G, Sutherland G, Zreiqat H, Lok H, Lyons G, Jansson P, Black J, Zhu L, Sunde M, Day M, Naylor M, Buckland M, Murray M, Shafie N, Lay P, Poronnik P, Codd R, Mason R, Ryan R, Christopherson R, de Graaf S; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2013

  • Robotic High Throughput Western Analysis for the Open Access, Multi-User Sydney Cancer Research Core Facility; Richardson D, Scolyer R, Boyer M, Halliday G, Damian D, Christopherson R, Joshua D, Kench J, Hong A, Murray M, Lee C, Kalinowski D, Naylor M, Lay P, Lyons G, Kovacevic Z, Mason R, Dixon K, Chan-Ling T, Hawkins C, Sunde M, Lovejoy D, Owens T, Rendina L, Jansson P, Dos Remedios C, Charles (nee Slaviero) K, Lane D, Witting P, Dong Q, Ammit A, Groundwater P, Assinder S, Bao B, Byrne S, Zhou F, Buckland M, Grewal T, Huq F, Lai D, Codd R, Zhang D, Fu D, de Graaf S, Huang M, Payne R, Slobedman B, Barrs V, Ho P, Williamson P, Murphy C; DVC Research/Equipment Grant.
  • QX100 Droplet Digital PCR system for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Richardson D, Kril J, Murphy C, Vandenberg R, Rendina L, Dos Remedios C, Ju Y, Kovacevic Z, Lyons G, Sutherland G, Lay P, Ammit A, Lai D, Morris B, Day M, Dong Q, Bao B, Huang M, Camp A, Boyer M, Whittington R, Byrne M, Hanrahan J, Fu D, Jansson P, Lane D, Bagley E, Hibbs D, Zhang D, Fraser S, Scolyer R, Black J, Halliday G, Christie M, Zreiqat H, Murray M, Slobedman B, Naylor M, Burgess J, Triccas J, Mason R, Chadban S, Combes V, Lovicu F, McLennan S, Kalinowski D, Sharland A, Johnstone D, Groundwater P, Dixon K, Zhou F, Lovejoy D, Lu Z, Zhu L, Goldsbury C, Witting P, Buckland M, Assinder S, Purdie (Williams) A, Codd R, Owens T, Hambly B; National Health and Medical Research Council (NHMRC)/Equipment Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Chiang, S., Kalinowski, D., Jansson, P., Richardson, D., Huang, M. (2018). Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia. Neurochemistry International, 117, 35-48. [More Information]
  • Al-Akra, L., Bae, D., Sahni, S., Huang, M., Park, K., Lane, D., Jansson, P., Richardson, D. (2018). Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones. Journal of Biological Chemistry, 293(10), 3562-3587. [More Information]
  • Anzovino, A., Chiang, S., Brown, B., Hawkins, C., Richardson, D., Huang, M. (2017). Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3(beta) Axis. American Journal of Pathology, 187(12), 2858-2875. [More Information]
  • Xi, R., Pun, I., Menezes, S., Fouani, L., Kalinowski, D., Huang, M., Zhang, X., Richardson, D., Kovacevic, Z. (2017). Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1). Molecular Pharmacology, 91(5), 499-517. [More Information]
  • Park, K., Fouani, L., Jansson, P., Wooi, D., Sahni, S., Lane, D., Palanimuthu, D., Lok, H., Kovacevic, Z., Huang, M., Kalinowski, D., Richardson, D. (2016). Copper and conquer: Copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics, 8(9), 874-886. [More Information]
  • Chiang, S., Kovacevic, Z., Sahni, S., Lane, D., Merlot, A., Kalinowski, D., Huang, M., Richardson, D. (2016). Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia. Clinical Science, 130(11), 853-870. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Richardson, V., Huang, M., Kalinowski, D., Richardson, D. (2016). Letter to the Editor: Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques"". International Journal of Molecular Sciences, 17(11), E1916. [More Information]
  • Kalinowski, D., Stefani, C., Toyokuni, S., Ganz, T., Anderson, G., Subramaniam, N., Trinder, D., Olynyk, J., Chua, A., Jansson, P., Sahni, S., Lane, D., Merlot, A., Kovacevic, Z., Huang, M., Richardson, D., et al (2016). Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics. Biochimica et Biophysica Acta, 1863 (4), 727-748. [More Information]
  • Paluncic, J., Kovacevic, Z., Jansson, P., Kalinowski, D., Merlot, A., Huang, M., Lok, H., Sahni, S., Lane, D., Richardson, D. (2016). Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling. Biochimica et Biophysica Acta, 1863 (4), 770-784. [More Information]
  • Sahni, S., Kovacevic, Z., Kalinowski, D., Huang, M., Menezes, S., Krishan, S., Lane, D., Jansson, P., Richardson, D. (2016). Targeting autophagy in antitumor agent design: Furthering the 'lysosomal love' strategy. Future Medicinal Chemistry, 8(7), 727-729. [More Information]
  • Wangpu, X., Lu, J., Xi, R., Yue, F., Sahni, S., Park, K., Menezes, S., Huang, M., Zheng, M., Kovacevic, Z., Richardson, D. (2016). Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling. Molecular Pharmacology, 89(5), 521-540. [More Information]
  • Lane, D., Merlot, A., Huang, M., Bae, D., Jansson, P., Sahni, S., Kalinowski, D., Richardson, D. (2015). Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochimica et Biophysica Acta - General Subjects, 1853 (5), 1130-1144. [More Information]
  • Merlot, A., Kalinowski, D., Kovacevic, Z., Jansson, P., Lane, D., Sahni, S., Huang, M., Richardson, D. (2015). Making a case for albumin - a highly promising drug-delivery system. Future Medicinal Chemistry, 7(5), 553-556. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Fordham, A., Pantarat, N., Hibbs, D., Richardson, V., Doddareddy, M., Ong, J., Huang, M., Richardson, D., Kalinowski, D. (2015). Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells. Oncotarget, 6(12), 10374-10398. [More Information]
  • Liu, W., Kovacevic, Z., Peng, Z., Jin, R., Wang, P., Yue, F., Zheng, M., Huang, M., Jansson, P., Richardson, V., Kalinowski, D., Lane, D., Merlot, A., Sahni, S., Richardson, D. (2015). The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: New therapeutic targets. Oncotarget, 6(34), 35522-35541. [More Information]
  • Liu, W., Yue, F., Zheng, M., Merlot, A., Bae, D., Huang, M., Lane, D., Jansson, P., Lui, G., Richardson, V., Sahni, S., Kalinowski, D., Kovacevic, Z., Richardson, D. (2015). The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget, 6(11), 8851-8874. [More Information]
  • Anzovino, A., Lane, D., Huang, M., Richardson, D. (2014). Fixing frataxin: "ironing out" the metabolic defect in friedreich's ataxia. British Journal of Pharmacology, 171(8), 2174-2190. [More Information]
  • Ellis, S., Kalinowski, D., Leotta, L., Huang, M., Jelfs, P., Sintchenko, V., Richardson, D., Triccas, J. (2014). Potent Anti-Mycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analogue, 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: A Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide. Molecular Pharmacology, 85(2), 269-278. [More Information]
  • Lane, D., Huang, M., Ting, S., Ramesh (Sivagurunathan), S., Richardson, D. (2013). Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia. The Biochemical Journal, 453(3), 321-336. [More Information]
  • Huang, M., Austin, C., Sari, M., Suryo Rahmanto, Y., Ponka, P., Vyoral, D., Richardson, D. (2013). Hepcidin Bound to α2-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels. Journal of Biological Chemistry, 288(35), 25450-25465. [More Information]
  • Lane, D., Huang, M., Richardson, D. (2013). Hepcidin, show some self-control! How the hormone of iron metabolism regulates its own expression. The Biochemical Journal, 452(2), e3-e5. [More Information]
  • Huang, M., Ramesh (Sivagurunathan), S., Ting, S., Jansson, P., Austin, C., Kelly, M., Semsarian, C., Zhang, D., Richardson, D. (2013). Molecular and Functional Alterations in a Mouse Cardiac Model of Friedreich Ataxia: Activation of the Integrated Stress Response, eIF2a Phosphorylation, and the Induction of Downstream Targets. American Journal of Pathology, 183(3), 745-757. [More Information]
  • Bae, D., Jansson, P., Huang, M., Kovacevic, Z., Kalinowski, D., Lee, C., Sahni, S., Richardson, D. (2013). The role of NDRG1 in the pathology and potential treatment of human cancers. Journal of Clinical Pathology, 66(11), 911-917. [More Information]
  • Whitnall, M., Suryo Rahmanto, Y., Huang, M., Saletta, F., Lok, H., Gutierrez, L., Lazaro, F., Fleming, A., ST Pierre, T., Mikhael, M., Richardson, D., et al (2012). Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proceedings of the National Academy of Sciences of the United States of America, 109(50), 20590-20595. [More Information]
  • Huang, M., Lane, D., Richardson, D. (2011). Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease. Antioxidants & Redox Signaling, 15(12), 3003-3019. [More Information]
  • Richardson, D., Lane, D., Becker, E., Huang, M., Suryo Rahmanto, Y., Sheftel, A., Ponka, P. (2010). Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proceedings of the National Academy of Sciences of the United States of America, 107(24), 10775-10782. [More Information]
  • Richardson, D., Huang, M., Whitnall, M., Becker, E., Ponka, P., Suryo Rahmanto, Y. (2010). The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. Journal of Molecular Medicine, 88(4), 323-329. [More Information]
  • Huang, M., Becker, E., Whitnall, M., Suryo Rahmanto, Y., Ponka, P., Richardson, D. (2009). Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proceedings of the National Academy of Sciences of the United States of America, 106(38), 16381-16386. [More Information]
  • Peslova, G., Petrak, J., Kuzelova, K., Hrdy, I., Halada, P., Kuchel, P., Soe-Lin, S., Ponka, P., Sutak, R., Becker, E., Huang, M., Suryo Rahmanto, Y., Richardson, D., Vyoral, D. (2009). Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood, 113(24), 6225-6236. [More Information]

2018

  • Chiang, S., Kalinowski, D., Jansson, P., Richardson, D., Huang, M. (2018). Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia. Neurochemistry International, 117, 35-48. [More Information]
  • Al-Akra, L., Bae, D., Sahni, S., Huang, M., Park, K., Lane, D., Jansson, P., Richardson, D. (2018). Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones. Journal of Biological Chemistry, 293(10), 3562-3587. [More Information]

2017

  • Anzovino, A., Chiang, S., Brown, B., Hawkins, C., Richardson, D., Huang, M. (2017). Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3(beta) Axis. American Journal of Pathology, 187(12), 2858-2875. [More Information]
  • Xi, R., Pun, I., Menezes, S., Fouani, L., Kalinowski, D., Huang, M., Zhang, X., Richardson, D., Kovacevic, Z. (2017). Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1). Molecular Pharmacology, 91(5), 499-517. [More Information]

2016

  • Park, K., Fouani, L., Jansson, P., Wooi, D., Sahni, S., Lane, D., Palanimuthu, D., Lok, H., Kovacevic, Z., Huang, M., Kalinowski, D., Richardson, D. (2016). Copper and conquer: Copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics, 8(9), 874-886. [More Information]
  • Chiang, S., Kovacevic, Z., Sahni, S., Lane, D., Merlot, A., Kalinowski, D., Huang, M., Richardson, D. (2016). Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia. Clinical Science, 130(11), 853-870. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Richardson, V., Huang, M., Kalinowski, D., Richardson, D. (2016). Letter to the Editor: Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques"". International Journal of Molecular Sciences, 17(11), E1916. [More Information]
  • Kalinowski, D., Stefani, C., Toyokuni, S., Ganz, T., Anderson, G., Subramaniam, N., Trinder, D., Olynyk, J., Chua, A., Jansson, P., Sahni, S., Lane, D., Merlot, A., Kovacevic, Z., Huang, M., Richardson, D., et al (2016). Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics. Biochimica et Biophysica Acta, 1863 (4), 727-748. [More Information]
  • Paluncic, J., Kovacevic, Z., Jansson, P., Kalinowski, D., Merlot, A., Huang, M., Lok, H., Sahni, S., Lane, D., Richardson, D. (2016). Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling. Biochimica et Biophysica Acta, 1863 (4), 770-784. [More Information]
  • Sahni, S., Kovacevic, Z., Kalinowski, D., Huang, M., Menezes, S., Krishan, S., Lane, D., Jansson, P., Richardson, D. (2016). Targeting autophagy in antitumor agent design: Furthering the 'lysosomal love' strategy. Future Medicinal Chemistry, 8(7), 727-729. [More Information]
  • Wangpu, X., Lu, J., Xi, R., Yue, F., Sahni, S., Park, K., Menezes, S., Huang, M., Zheng, M., Kovacevic, Z., Richardson, D. (2016). Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling. Molecular Pharmacology, 89(5), 521-540. [More Information]

2015

  • Lane, D., Merlot, A., Huang, M., Bae, D., Jansson, P., Sahni, S., Kalinowski, D., Richardson, D. (2015). Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochimica et Biophysica Acta - General Subjects, 1853 (5), 1130-1144. [More Information]
  • Merlot, A., Kalinowski, D., Kovacevic, Z., Jansson, P., Lane, D., Sahni, S., Huang, M., Richardson, D. (2015). Making a case for albumin - a highly promising drug-delivery system. Future Medicinal Chemistry, 7(5), 553-556. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Fordham, A., Pantarat, N., Hibbs, D., Richardson, V., Doddareddy, M., Ong, J., Huang, M., Richardson, D., Kalinowski, D. (2015). Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells. Oncotarget, 6(12), 10374-10398. [More Information]
  • Liu, W., Kovacevic, Z., Peng, Z., Jin, R., Wang, P., Yue, F., Zheng, M., Huang, M., Jansson, P., Richardson, V., Kalinowski, D., Lane, D., Merlot, A., Sahni, S., Richardson, D. (2015). The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: New therapeutic targets. Oncotarget, 6(34), 35522-35541. [More Information]
  • Liu, W., Yue, F., Zheng, M., Merlot, A., Bae, D., Huang, M., Lane, D., Jansson, P., Lui, G., Richardson, V., Sahni, S., Kalinowski, D., Kovacevic, Z., Richardson, D. (2015). The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget, 6(11), 8851-8874. [More Information]

2014

  • Anzovino, A., Lane, D., Huang, M., Richardson, D. (2014). Fixing frataxin: "ironing out" the metabolic defect in friedreich's ataxia. British Journal of Pharmacology, 171(8), 2174-2190. [More Information]
  • Ellis, S., Kalinowski, D., Leotta, L., Huang, M., Jelfs, P., Sintchenko, V., Richardson, D., Triccas, J. (2014). Potent Anti-Mycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analogue, 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: A Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide. Molecular Pharmacology, 85(2), 269-278. [More Information]

2013

  • Lane, D., Huang, M., Ting, S., Ramesh (Sivagurunathan), S., Richardson, D. (2013). Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia. The Biochemical Journal, 453(3), 321-336. [More Information]
  • Huang, M., Austin, C., Sari, M., Suryo Rahmanto, Y., Ponka, P., Vyoral, D., Richardson, D. (2013). Hepcidin Bound to α2-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels. Journal of Biological Chemistry, 288(35), 25450-25465. [More Information]
  • Lane, D., Huang, M., Richardson, D. (2013). Hepcidin, show some self-control! How the hormone of iron metabolism regulates its own expression. The Biochemical Journal, 452(2), e3-e5. [More Information]
  • Huang, M., Ramesh (Sivagurunathan), S., Ting, S., Jansson, P., Austin, C., Kelly, M., Semsarian, C., Zhang, D., Richardson, D. (2013). Molecular and Functional Alterations in a Mouse Cardiac Model of Friedreich Ataxia: Activation of the Integrated Stress Response, eIF2a Phosphorylation, and the Induction of Downstream Targets. American Journal of Pathology, 183(3), 745-757. [More Information]
  • Bae, D., Jansson, P., Huang, M., Kovacevic, Z., Kalinowski, D., Lee, C., Sahni, S., Richardson, D. (2013). The role of NDRG1 in the pathology and potential treatment of human cancers. Journal of Clinical Pathology, 66(11), 911-917. [More Information]

2012

  • Whitnall, M., Suryo Rahmanto, Y., Huang, M., Saletta, F., Lok, H., Gutierrez, L., Lazaro, F., Fleming, A., ST Pierre, T., Mikhael, M., Richardson, D., et al (2012). Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proceedings of the National Academy of Sciences of the United States of America, 109(50), 20590-20595. [More Information]

2011

  • Huang, M., Lane, D., Richardson, D. (2011). Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease. Antioxidants & Redox Signaling, 15(12), 3003-3019. [More Information]

2010

  • Richardson, D., Lane, D., Becker, E., Huang, M., Suryo Rahmanto, Y., Sheftel, A., Ponka, P. (2010). Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proceedings of the National Academy of Sciences of the United States of America, 107(24), 10775-10782. [More Information]
  • Richardson, D., Huang, M., Whitnall, M., Becker, E., Ponka, P., Suryo Rahmanto, Y. (2010). The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. Journal of Molecular Medicine, 88(4), 323-329. [More Information]

2009

  • Huang, M., Becker, E., Whitnall, M., Suryo Rahmanto, Y., Ponka, P., Richardson, D. (2009). Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proceedings of the National Academy of Sciences of the United States of America, 106(38), 16381-16386. [More Information]
  • Peslova, G., Petrak, J., Kuzelova, K., Hrdy, I., Halada, P., Kuchel, P., Soe-Lin, S., Ponka, P., Sutak, R., Becker, E., Huang, M., Suryo Rahmanto, Y., Richardson, D., Vyoral, D. (2009). Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood, 113(24), 6225-6236. [More Information]

To update your profile click here. For support on your academic profile contact .